In vitro pharmacoregulation of CC chemokine ligand 5 and its receptor CCR5 in diffuse lung diseases

In vitro pharmacoregulation of CC chemokine ligand 5 and its receptor CCR5 in diffuse lung diseases

Background: CC chemokine ligand (CCL)5 and its receptor CCR5 contribute to leukocyte migration into lungs of patients with diffuse lung diseases (DLD). Pharmacological regulation of CCL5 and CCR5 expression was therefore explored in bronchoalveolar cells obtained from patients with DLD.

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Veronika Sekerova, Daniela Subrtova, Frantisek Mrazek, Agata Gibejova, Vitezslav Kolek, Roland M. du Bois, Martin Petrek
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Hindawi Limited 2003-01-01
Sraith:Mediators of Inflammation
Ábhair:
Dexamethasone
Cyclosporin A
Pentoxifylline
Sarcoidosis
RANTES
Glucocorticoids
Bronchoalveolar cells.
Rochtain ar líne:http://dx.doi.org/10.1080/09629350310001599657

Ar líne

http://dx.doi.org/10.1080/09629350310001599657

Míreanna comhchosúla